1887
2 - Second Qatar Allergy Conference
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Soluble anti-antigen antibodies (Anti-ENA) represent a specificity of anti-nuclear autoantibodies (ANA), which are directed against nuclear particles composed of small RNA (Ribonucleic acid) and proteins. They are found during certain autoimmune diseases (ADs), most frequently during systemic lupus erythematosus (SLE) and Gougerot syndrome. The aim of this study is to retrospectively analyze the positive serum for Anti-ENA antibodies and associated pathologies.

This study was carried out at the Immunology Department, Central Laboratory of Medical Analysis, University Hospital Hassan II - Fez, Morocco, for a period of 2 years. 821 serum samples were included. The indirect immunofluorescence method (IFI) was used to search the ANAs in the serums. In the case of a positive result, an identification of the antigenic targets was performed by the Immunodot technique according to the supplier’s recommendations (D-Tek).

Eighty-eight serums were found positive for anti-ENA antibodies. The mean age in our series was 41 ±15.5 years. There were 80 women and 8 men with a sex ratio F/M of 10. The results by associated pathologies show a strong association of the anti-ENA antibodies’ positivity with lupus and Gougerot syndrome.

Anti-ENA antibodies are important immunological markers for lupus and Gougerot syndrome diagnosis.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2023.sqac.29
2023-05-15
2024-03-03
Loading full text...

Full text loading...

References

  1. Chakar Charki. Le profil des anticorps antinucleaires dans les maladies auto-immunes systemiques. Universite Mohammed V-Rabat Faculte de Medecine et de Pharmacie RABAT. 2019.
    [Google Scholar]
  2. Theander E, et al. Prediction of Sjogren’s Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling. Arthritis Rheumatol. 2015; 67:(9):2427–36.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2023.sqac.29
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error